Next Article in Journal
Effects of Lifestyle, Diet, and Body Composition on Free Testosterone and Cortisol Levels in Young Men
Next Article in Special Issue
Effects of a Red-Ginger-Based Multi-Nutrient Supplement on Optic Nerve Head Blood Flow in Open-Angle Glaucoma
Previous Article in Journal
The Real Danger for Milk Protein Allergy: Developing a Scale for Family Doctors on Introducing Diet Diversity to Infants with Cow’s Milk Protein Allergy
Previous Article in Special Issue
Stimulatory Effects of (+)-Epicatechin on Short- and Long-Term Memory in Aged Rats: Underlying Mechanisms
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Rhubarb-Derived Extracellular Vesicles Mitigate Oxidative Stress and Metabolic Dysfunction in an Alzheimer’s Cellular Model

1
Department of Chemistry, Biology and Biotechnology, University of Perugia, 06100 Perugia, Italy
2
Centro di Digitalizzazione del Patrimonio Culturale (CeDiPa), University of Perugia, 06123 Perugia, Italy
3
Department of Biology, Science Faculty, Selcuk University, Konya 42130, Turkey
4
Centro di Eccellenza Materiali Innovativi Nanostrutturati (CEMIN), University of Perugia, Via del Giochetto, 06123 Perugia, Italy
*
Author to whom correspondence should be addressed.
Nutrients 2025, 17(23), 3771; https://doi.org/10.3390/nu17233771
Submission received: 31 October 2025 / Revised: 27 November 2025 / Accepted: 28 November 2025 / Published: 30 November 2025

Abstract

Background/Objectives: Extracellular vesicles derived from edible plants have emerged as bioactive nanostructures with potential therapeutic and nutraceutical properties and are currently being investigated as natural carriers for the treatment of oxidative stress-induced damage and oxidative stress-related diseases, including neurodegenerative disorders such as Alzheimer’s disease (AD). Recent studies suggest that PDEVs exhibit high stability within the gastrointestinal tract and selective tissue-targeting abilities, facilitating the efficient delivery of bioactive molecules. Methods: This study investigates the antioxidant effects of Rheum rhabarbarum-derived EVs by assessing the antioxidant activity through different in vitro assays and their effects on oxidative stress and energy metabolism in the cellular model of Alzheimer’s disease. Results: Rhubarb-derived EVs showed measurable antioxidant capacity in chemical assays and were non-toxic under the tested conditions. Treatment reduced intracellular ROS levels and modulated oxidative stress-related proteins, suggesting a potential protective effect against oxidative damage. Moreover, metabolic analysis revealed a decrease in glycolytic activity, indicating a potential restoration of cellular bioenergetic homeostasis. Conclusions: These results provide preliminary evidence supporting the nutraceutical interest of rhubarb-derived EVs in counteracting oxidative stress, while further studies will be needed to confirm their biological relevance and therapeutic potential.

1. Introduction

Chronic diseases represent a growing challenge for public health globally, stimulating the search for new therapeutic strategies [1]. In this context, natural products, especially bioactive compounds of plant origin, have attracted considerable attention for their potential in the treatment of several complex diseases. The genus Rheum (Polygonaceae) includes about 60 species of perennial herbaceous plants, widely used for their therapeutic properties [2,3,4]. Recent studies have confirmed the value of these plants, revealing the presence of compounds with interesting biological activities, including stilbenoids, tannins, and anthraquinones [2,3,5]. The most studied species are R. rhaponticum, R. rhabarbarum, and R. lhasaense, characterized by a rich phytochemical composition and a wide range of biological activities. R.rhaponticum and R. rhabarbarum are known for their abundance in stilbenes, anthraquinones, and flavonoids, compounds that confer antioxidant, anti-inflammatory, and antimicrobial properties to these plants [6,7,8,9]. It has been demonstrated that R. rhaponticum extract exerts cardiovascular protection and modulates bone metabolism, with positive effects on bone mineral density and regulation of the estrogenic signaling pathway, while both R. rhaponticum and R. rhabarbarum extracts also exhibit significant anti-inflammatory and antioxidant activities [7,10,11]. Current research focuses on the identification of novel compounds, the characterization of their biochemical properties, and their potential application in the treatment of chronic diseases. In this context, plant-derived extracellular vesicles (PDEVs) have shown significant attention in recent years. These nanometric membranous particles (50–500 nm) play different roles within plant cells [12,13]. Although their mechanisms of action are not fully understood, their most well-documented role is in protecting plants against pathogens such as fungi, bacteria, and viruses [14,15]. One of the key characteristics of these vesicles is their stability, which allows them to protect biochemical components from environmental degradation. This property facilitates the transfer of molecular signals between different organisms, supporting intercellular communication among plant cells, animals, and microorganisms [16]. In fact, although plant-derived phytochemicals can be effectively extracted, many natural compounds tend to degrade or be metabolized into inactive derivatives in the circulatory system [17]. Beyond their role in plant defenses, PDEVs are naturally present in edible plant tissues and, consequently, are introduced into the human body through the diet [18,19,20]. For this reason, it has been hypothesized that they may contain bioactive biomolecules that reflect the characteristics of the plant cells of origin [13,21]. Recent studies have demonstrated that PDEVs exhibit high stability in the gastrointestinal tract and are efficiently internalized by mammalian cells, protecting encapsulated biomolecules from degradation and enabling their biological activity [22]. Upon reaching the target site, these vesicles can be internalized through endocytic pathways, facilitating the controlled release of their cargo and modulating key biological processes with antioxidant, anti-inflammatory, and antitumor effects [19]. In contrast to plant extracts, which, despite their high content of bioactive molecules, also have a complex potentially cytotoxic matrix that limits their bioavailability, PDEVs represent a more effective delivery system, ensuring greater selectivity and stability of the bioactive molecules [21,23]. This aspect has led to a growing interest in their use as natural food supplements, both for their intrinsic properties and as vehicles for the administration of bioactive compounds added after their isolation. Amid the growing interest in PDEVs, there is also their potential relevance to neurodegenerative diseases such as Alzheimer’s disease (AD). AD is characterized by progressive neuronal dysfunction accompanied by chronic neuroinflammation and higher oxidative stress, which contribute to synaptic loss and cognitive decline [24,25]. Oxidative damage to lipids, proteins, and nucleic acids is among the earliest detectable pathological events in AD, while prolonged activation of microglia and astrocytes perpetuates inflammatory cascades that exacerbate neuronal damage. Natural compounds with antioxidant and anti-inflammatory properties have therefore attracted considerable attention for their potential neuroprotective effects, and several plant-derived molecules, such as polyphenols, stilbenes, and flavonoids, have shown beneficial effects in cellular and animal models of AD [26,27,28]. Given that Rheum species are rich in antioxidant and anti-inflammatory phytochemicals, and that PDEVs can protect and deliver these molecules in a stable and bioavailable form, rhubarb-derived EVs may represent a promising candidate for counteracting oxidative stress and inflammatory pathways relevant to AD pathology.
This study aimed to isolate and characterize PDEVs from the rhizome of R. rhabarbarum and assess their antioxidant potential through in vitro assays and a fibroblast model of Alzheimer’s disease (AD), which exhibits systemic oxidative stress alterations relevant to AD. By combining biochemical and molecular analyses, it was possible to explore their concentration, morphology, and functional activity, and to offer new insights into their therapeutic potential as bioactive compounds.

2. Materials and Methods

2.1. Materials

Rhizoma of Rheum rhabarbarum L. was purchased from the local nursery. 2-(N-Morpholino)Ethanesulfonic Acid (MES), calcium chloride (CaCl2), sodium chloride (NaCl), methanol, and ethanol were purchased from Sigma Aldrich (St. Louis, MO, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 2′,7′-Dichlorodihydrofluorescein diacetate, Phosphate-Buffered Saline (PBS), Dimethyl Sulfoxide (DMSO), glutaraldehyde (25%), 2,2-Diphenyl-1-picrylhydrazyl (DPPH), ABTS radical cation (2,2′-azino-bis(3-ethylbenzothiazoline)-6-sulphonic acid), TPTZ (2,4,6-tri(2-pyridyl)-s-triazine), FeCl3, Cu(II), neucoproine and Trolox were purchased from Sigma-Aldrich. Human dermal fibroblasts (HDFs) were obtained from the waste of skin biopsies of both healthy donors (HDF CTRL) and patients diagnosed with Alzheimer’s disease, classified as Clinical Dementia Rating scale 2 (HDF AD CDR2). In both cases, the isolation of HDF cells occurred occasionally, and all procedures were conducted with the informed consent of donors, adhering to the principles of the Helsinki Declaration [29]. The study was approved by the University of Perugia Ethics Committee with approval number Prot. N. CE-2492/25 (7/23/2025). The cells were cultured under standard conditions. Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), trypsin, and penicillin/streptomycin were purchased from Euroclone (Pero, Italy). All the other chemicals were of analytical grade and were obtained from Sigma-Aldrich unless otherwise indicated. Seahorse XF Glycolytic Rate Assay Kit, XF DMEM, XF glutamine, XF pyruvate, and XF glucose were purchased from Agilent (Agilent, Santa Clara, CA, USA).

2.2. PDEVs from Rheum Rhabarbarum Purification Method

For the isolation of EVs from Rhubarb rhizome, 2.5 g of dried material was weighed and resuspended in 10 mL of VIB buffer (20 mM MES, 2 mM CaCl2, 0.1 M NaCl, pH 6.0) and left under agitation overnight at 4 °C to allow rehydration. EVs’ enriched fraction isolation was performed using differential ultracentrifugation (dUC) [30]. First, centrifugation was carried out at 700× g for 20 min at 4 °C, and then the recovered liquid was filtered through a 0.45 µm membrane to remove possible debris. Subsequently, filtered samples underwent sequential centrifugation at increasing speeds (10,000× g for 60 min and 100,000× g for 60 min). The final pellet was then resuspended in 200 µL of PBS with 10% DMSO for biological assays, 100 µL of ethanol to test antioxidant activity, and 200 µL of methanol for QTOF LC/MS analysis. Moreover, the isolation of EVs was also performed by size-exclusion chromatography (SEC). EVs isolated using dUC and suspended in 200 µL of PBS were loaded on the ready-made columns IZON 70 nm (IZON Science, Cambridge, MA, USA). A total of 12 fractions (a 500 µL volume for each) were collected by using the extraction buffer for elution. Protein quantity in each fraction was measured using the Bradford assay [31]. EVs isolated by SEC were then analyzed in terms of concentration and morphology by NTA.

2.3. Nanoparticle Tracking Analysis (NTA) and Scanning Electron Microscopy (SEM)

The EV concentration and size distribution were analyzed using Malvern Panalytical NanoSight NS300 (NTA) (Malvern, Westborough, MA, USA). Rhubarb rhizome EVs were diluted in filtered PBS and analyzed with five measurements per sample in two independent experiments, as previously described [21]. For SEM, EVs were resuspended in 50 µL of PBS Buffer (0.22 µm filtered), and protein quantification was performed using the Bradford method [31]. A quantity corresponding to 2 µg of proteins was diluted in 2 mL of 2.5% glutaraldehyde (v/v in PBS 1X) and fixed for 15 min. Subsequently, the samples were diluted in 15 mL of dd-water (0.22 µm filtered), placed in Vivaspin tubes (300 KDa cutoff), and centrifuged (3000× g, 3 min). After removing the eluate, EVs were washed twice with 10 mL of water and centrifuged under the same conditions. Two dilutions (1:500 and 1:1000) were prepared, and 20 µL of each was seeded onto 12 mm diameter glass coverslips and successively fixed and coated with a thin conductive layer for electron microscopy.

2.4. Dynamic Light Scattering (DLS)

The zeta potential of Rheum rhabarbarum EVs was measured using a Nicomp® Nano N3000 Dynamic Light Scattering (DLS) system (Entegris, Billerica, MA, USA). This instrument was employed to determine the surface charge of the nanoparticles through zeta potential analysis. The system is equipped with a high-power red laser diode (15–100 mW, 630 nm) and two detectors, PMT and APD, positioned at 90 degrees. The applicable electric field can be adjusted from 1 to 250 V/cm. The Nicomp algorithm also allows for the resolution of close multi-modal distributions with high resolution.

2.5. Immunoblotting Analysis

The presence of plant vesicular marker TET8 in rhubarb-derived EVs was evaluated by immunoblotting analysis. Here, 10 μg of total protein of EVs or R. rhabarbarum crude extract were mixed with 5× sample buffer (1 M Tris-HCl, pH 6.8, 5% SDS, 6% glycerol, 0.01% bromophenol blue) supplemented with 125 mM DTT. Samples were heated at 95 °C for 5 min and subjected to SDS-PAGE on 10% acrylamide gels. Gels were transferred onto polyvinylidene difluoride (PVDF) membranes using the Trans-Blot Turbo Transfer System (Bio-Rad, Hercules, CA, USA). After blocking, membranes were incubated overnight at 4 °C with a primary antibody against TET8 from PhytoAB (San Jose, CA, USA) and Calnexin from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Detection was performed using HRP-conjugated secondary antibodies (Cell Signaling Technology, Beverly, MA, USA) and visualized via enhanced chemiluminescence (ECL) (GE Biosciences, Piscataway, NJ, USA).

2.6. In Vitro Antioxidant Capacity

The DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging capacity of Rheum rhabarbarum rhizoma EVs was assessed through the Blois method with few modifications [32]. Briefly, 50 μL of EVs was combined with 150 μL of freshly prepared DPPH solution. The mixture was then vigorously shaken and incubated in the dark at room temperature for 30 min. After incubation, the absorbance was recorded at 517 nm with an Infinite Tecan Spectrophotometer (Tecan Group Ltd., Mannedorf, Switzerland). The ABTS+ free radical scavenging activity was assessed following the method described by Miller et al. (1993) [33]. The ABTS+ radical was generated through the oxidation of ABTS with potassium persulfate. The stock solution of ABTS+ was then diluted in methanol to achieve an absorbance of 0.700 ± 0.020 at 734 nm. Also in this case, 50 μL of EVs was mixed with 150 μL of the diluted ABTS+ solution, and the absorbance was recorded at 734 nm after 6 min of incubation in the dark at room temperature.
In both cases, the percentage of DPPH and ABTS radical scavenging was calculated using the formula [34]:
%   Scavenging   effect = A 0 A 1 A 0 × 100
where A0 represents the absorbance of the control, and A1 corresponds to the absorbance of the sample.
The antioxidant capacity was also assessed using the FRAP (Ferric-Reducing Antioxidant Power) and CUPRAC (Cupric-Reducing Antioxidant Capacity) assays, following the previously described protocol [35]. For the FRAP assay [36], the reagent was prepared by mixing 300 mM acetate buffer, 10 mM TPTZ (2,4,6-tri(2-pyridyl)-s-triazine) in 40 mM HCl, and 20 mM FeCl3 in a volume ratio of 10:1:1. Then, 10 µL of the sample was mixed with 190 µL of FRAP reagent, and the mixture was incubated in the dark for 30 min at room temperature. Absorbance was measured at 593 nm using the Infinite Tecan instrument (Tecan Group Ltd., Mannedorf, Switzerland), and results were expressed as micromol of Trolox equivalents (TE) per 106 particles per mL. If the absorbance exceeded the linear range of the Trolox standard curve, the sample was appropriately diluted. For the CUPRAC assay, the reagent was prepared by mixing 10 mM Cu(II), 7.5 mM alcoholic neocuproine solution, and 1 M acetate buffer (pH 7) in a volume ratio of 1:1:1. A total of 30 µL of the sample or Trolox standard solution was added to 170 µL of CUPRAC reagent and incubated for 30 min in the dark. Absorbance was measured at 450 nm using the Infinite Tecan reader (Tecan Group Ltd., Mannedorf, Switzerland). Also, in this case, results were expressed as micromol of Trolox equivalents (TE) per 106 particles per mL.

2.7. Determination of Total Phenolic Content (TPC)

The total phenolic content of rhubarb-derived EVs was determined using the Folin–Ciocalteu assay [37]. A standard calibration curve was prepared using gallic acid as the reference compound. A volume of 50 µL of rhubarb-derived EVs was mixed with 150 µL of Folin–Ciocalteu reagent, which was previously diluted 10-fold with deionized water. The mixture was thoroughly vortexed and incubated for 5 min at room temperature. Subsequently, 150 µL of 20% Na2CO3 solution was added, and the reaction mixture was kept in the dark for 30 min at room temperature. The absorbance was measured at 750 nm using an Infinite Tecan Spectrophotometer (Tecan Group Ltd., Mannedorf, Switzerland). The results were expressed as micrograms of gallic acid equivalents per 106 particles.

2.8. Untargeted Analysis of Polyphenol Content by Q-TOF LC/MS Mass Spectrometry

The extraction of polyphenols from rhubarb-derived EVs was performed by adding 40 µL of the extraction solution (70% methanol with 3% formic acid) to EV samples. After extraction solution addition, the samples were vortexed for 10 min using a thermomixer (Eppendorf, Hamburg, Germany) and centrifuged at 10,000× g for 10 min at 4 C. The resulting supernatant was collected and transferred into glass vials for subsequent injection into the mass spectrometer. Untargeted polyphenol profiling was performed using an Agilent 1260 Infinity II liquid chromatograph (Agilent, Santa Clara, CA, USA) coupled with an Agilent 6530 Accurate-Mass Q-TOF (quadrupole time-of-flight) mass spectrometer equipped with an Agilent JetStream electrospray ionization (ESI) source. Chromatographic separation was carried out using a Waters Acquity XBridge BEH Amide (HILIC) C18 column (Waters Corporation, Milford, MA, USA) (150 mm × 2.1 mm, 2.51.7 µm) maintained at 25–30 °C, with a mobile phase flow rate of 0.35 mL/min. The mobile phase consisted of water (Solvent A) and acetonitrile (Solvent B), both containing 0.2% formic acid. The chromatographic conditions were optimized based on previously published methods [38]. The gradient used was as follows: a linear gradient from 0 min (B = 5%) to 15 min (B = 45%), followed by another linear gradient from 15 min (B = 45%) to 18 min (B = 95%). The composition was then held at B = 95% from 18 to 20 min, before returning to B = 5% at 20.1 min. The run stopped at 23 min. The mass spectrometer operated in both positive and negative ionization modes under the following conditions: ion spray voltage at 3500 V, gas temperature at 250 °C, sheath gas temperature at 300 °C, nebulizer pressure at 35 psi, and sheath gas flow at 12 L/min. Data-dependent acquisition was applied in the 40–1700 m/z range for both MS and MS/MS, with a collision energy of 30 V.
Raw data were processed for peak detection and compound annotation using Qualitative Analysis MassHunter software (version 4.9) [21] and MS-DIAL software (version 4.9). Since no internal standards were used, the relative concentration of each detected polyphenol was estimated based on its contribution to the total phenolic content (TPC) determined via spectrophotometry [37]. The TPC value was used as a reference to express the relative percentage abundance of individual polyphenol species. Three independent replicates were performed for each sample.

2.9. Cell Treatments

2.9.1. Cell Culture

Human dermal fibroblasts (CTRL and AD) were used as an in vitro model to evaluate the antioxidant activity of R. rhabarbarum EVs. The isolation of human dermal fibroblasts occurred from waste materials from two patients who underwent surgical procedures, and all procedures were conducted adhering to the principles of the Helsinki Declaration. The HDF CTRL and HDF AD cell lines were cultured in a Dulbecco’s modified Eagle’s medium (DMEM) containing 10% (v/v) heat-inactivated FBS and penicillin 10,000 U per mL/streptomycin 10 mg per mL and incubated in a humidified atmosphere (5% CO2 at 37 °C).

2.9.2. R. rhabarbarum EV Cellular Uptake

To evaluate the cellular uptake of rhubarb-derived EVs, HDF cells were incubated with EVs previously labeled with 1,1′-Dioctadecyl-3,3,3′,3′-Tetramethylindocarbocyanine Perchlorate (DiL; Thermo Fisher Scientific, Carlsbad, CA, USA) and analyzed by fluorescence microscopy. For vesicle labeling, 50 µM DiL was added to the supernatant obtained after centrifugation at 10,000× g, while PBS processed in parallel was used as a negative control. After 30 min of incubation at room temperature, the excess dye was removed by washing the EVs with PBS through ultracentrifugation at 100,000× g for 70 min at 4 °C. For the uptake assay, HDF cells (5 × 104) were exposed to the DiL-labeled NVs for 1 h, fixed with 4% paraformaldehyde for 20 min, and stained with FITC-conjugated phalloidin for 30 min to visualize F-actin filaments. Nuclei were counterstained using VECTASHIELD® Vibrance Antifade Mounting Medium (Sigma-Aldrich, St. Louis, MO, USA) containing DAPI. Fluorescence images were acquired with a Nikon Eclipse TE2000-S fluorescence microscope (Minato City, Japan) equipped with an F-View II FireWire camera (Olympus Soft Imaging Solutions) and analyzed using CellF Imaging Software (Olympus Soft Imaging Solutions) [39].

2.9.3. MTT Cytotoxicity Assay

To assess the effect of R. rhabarbarum EVs on cell proliferation, the MTT assay was performed [21]. Specifically, 1 × 104 HDF CTRL and HDF AD cells were seeded in 96-well clear flat-bottom microplates in 100 μL of DMEM culture medium. After 24 h, the medium was replaced with 100 μL of fresh medium containing different dilutions of EVs. Each dilution was tested in octuplicates, with one set of wells serving as a control (100 μL of DMEM) and additional octuplicates used to account for the effects of PBS + DMSO (vehicle controls) at the same concentrations as the tested samples. The following day, the MTT assay was carried out as previously described [21]. Cell viability was calculated as the optical density percentage of treated cells compared to vehicle controls, assuming the control absorbance as 100% (absorbance of treated wells/absorbance of control wells × 100) using a Tecan Infinite Spectrophotometer (Tecan Group Ltd., Mannedorf, Switzerland).

2.9.4. Trypan Blue Exclusion Assay

Cell growth was also monitored using Trypan blue dye staining with an automated cell counter (Invitrogen™ Countess™, Thermo Fisher Scientific, Waltham, MA, USA). Specifically, 5 × 104 HDF CTRL and HDF AD cells were seeded into Falcon® 24-well clear flat-bottom plates (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) in triplicate. After 24 h, the culture medium was replaced with 500 µL of fresh medium containing different dilutions of EVs. Cell growth was assessed at 24 h using a 0.04% Trypan blue solution (Sigma-Aldrich, St. Louis, MO, USA).

2.9.5. Intracellular ROS Production Assay

Intracellular ROS levels were assessed using the H2DCFHDA assay, which detects DCF fluorescence generated in the presence of ROS, as previously described [21]. Briefly, 10 × 103 HDF CTRL and HDF AD cells were seeded into a 96-well black round-bottom polystyrene microplate with 100 μL of DMEM culture medium. The following day, CTRL and HDF AD cells were exposed to hydrogen peroxide (H2O2) at 250 µM, with or without co-treatment with Rheum rhabarbarum EVs at a high concentration corresponding to ~1.1 × 106 particles. A quadruplet was kept as vehicle control to take into account the effect of DMSO. After 24 h, the H2DCFHDA assay was performed, and the fluorescence intensity of oxidized DCF was measured. Data, expressed as the percentage of DCF fluorescence intensity relative to vehicle controls, were normalized to cell viability, which was evaluated using the MTT assay. For this, cells were seeded in parallel onto a 96-well clear flat-bottom microplate and subjected to the same treatments and conditions. All measurements were performed in quadruplicate across three independent experiments.

2.9.6. Immunoblot Analysis in CTRL and AD Cells

To assess the antioxidant activity of R. rhabarbarum EVs, 1.5 × 105 cells were seeded in 6-well clear flat-bottom microplates in 1000 μL of DMEM culture medium. The following day, the medium was replaced with 1000 μL of fresh medium containing EVs at high concentrations corresponding to 1.1 × 106 particles. After treatment, cells were incubated for 24 h, and cell lysate (30 μg) was subjected to 10% SDS-PAGE under reducing conditions following Laemmli’s method [40]. Proteins were then transferred onto a polyvinylidene difluoride (PVDF) membrane, as previously described [21]. The PVDF membrane was incubated overnight at 4 °C for 12 h with primary antibodies targeting Catalase, SOD1, and COX IV, followed by detection using the ECL (enhanced chemiluminescence) system, and images were acquired with an iBright 1500 imager system. Densitometric analysis of immunoblot images was performed using ImageJ software (version 1.54p).

2.10. Seahorse Glycolytic Activity Analysis

To evaluate the effect of R. rhabarbarum EVs on the glycolytic activity of CTRL and AD cells, the Agilent Seahorse XFp Extracellular Flux Analyzer (Agilent, Santa Clara, CA, USA). was used following the Glycolytic Rate Assay protocol. Cells were seeded at a density of 2.5 × 104 cells/well, previously optimized to ensure linear signal response and avoid oxygen diffusion limitations, in XFp Cell Culture Microplates (Agilent, Santa Clara, CA, USA)., and after 24 h, the medium was replaced with fresh medium for CTRL and AD cells, and with fresh medium containing R. rhabarbarum EVs at high concentrations (1.1 × 106 particles/mL, applied for 24 h). The following day, the medium was replaced with phenol red-free XF DMEM supplemented with 10 mM glucose, 2 mM sodium pyruvate, and 2 mM glutamine. Mitochondrial respiration was inhibited by adding Rotenone (0.5 µM) and Antimycin A (0.5 µM) (Rot/AA), which block the electron transport chain and prevent CO2-derived proton production. Then, 2-deoxy-D-glucose (2-DG), a glucose analogue, was introduced to competitively inhibit hexokinase, the key enzyme initiating glycolysis, thereby suppressing glycolytic activity. The effects of these treatments were assessed by measuring the Proton Efflux Rate (PER), a key parameter for determining glycolytic activity resulting from cellular metabolism [41,42]. All Seahorse parameters were normalized to protein content per well, determined by the Bradford assay, and each experiment was performed with at least three technical replicates and three independent biological replicates. Data were analyzed using Seahorse Wave software.

2.11. Statistical Analysis

The data shown in this study are reported as the mean values of three independent experiments, and differences among the samples were assessed using an ANOVA test. All statistical tests were performed using GraphPad Prism 9.00.

3. Results

3.1. Rhubarb-Derived Extracellular Vesicle Characterization: NTA and SEM Analysis

The presence of rhubarb-derived EVs in the enriched fractions determined through morphological analysis was first assessed by Scanning Electron Microscopy (SEM) (Figure 1a). SEM images revealed the presence of round-shaped vesicular structures with a heterogeneous size distribution, displaying a slightly textured surface. Nanoparticle tracking analysis (NTA) was then performed on the enriched EV fraction obtained after differential ultracentrifugation (Figure 1b). The results demonstrated that rhubarb EVs had a mean size of approximately 144.6 ± 7.8 nm, with a mode size of 133.2 ± 1.8 nm. Additionally, the total EV yield was quantified, reaching approximately 4.4 × 109 particles/g of rhizome starting material. Moreover, the enriched rhubarb-derived EV zeta potential resulted in negative values (−14.65 mV) (Figure S1). These values are comparable to other PDEV zeta potentials and provide an indirect measure of EVs’ colloidal stability, which controls both vesicle–vesicle and vesicle–medium interactions.
To further improve purity, the enriched EV fraction was subjected to size-exclusion chromatography (SEC) using a 70 nm cutoff column. Twelve fractions were collected and analyzed by NTA (Figure S2). Fractions 7 and 8 exhibited the highest particle concentrations (1.2 × 109 and 1.6 × 109 particles/mL, respectively) and showed monodisperse size profiles centered at approximately 136 nm (Fr. 7) and 200 nm (Fr. 8) (Figure 1c). The ratio of the number of particles per μg of protein was determined as a quantification of the purity of EV preparations. This ratio was above 2 × 109 for fraction t and 2 × 109 for fraction 8, which, according to Webber and Clayton, corresponds to pure EV samples [43].
To validate the vesicular nature of the rhubarb-derived EVs, immunoblotting for the plant EV marker TET8 was performed on the enriched fraction and on SEC fractions 7 and 8 (Figure 1d). A clear positive signal for TET8 was detected in all EV-containing samples, corroborating the NTA results regarding vesicle enrichment and size homogeneity. In parallel, a crude extract from Rheum rhabarbarum was analyzed as a negative control. Calnexin, an endoplasmic reticulum protein commonly used as a non-EV marker, was detected only in the crude extract and not in the enriched or purified EV samples. This confirms the efficiency of the combined differential ultracentrifugation and SEC separation and the high purity of the isolated rhubarb-derived EVs.
Although plant-derived EVs are heterogeneous, both the enriched fraction obtained through differential ultracentrifugation and the SEC-purified fractions displayed a monodisperse size profile. The slight shift in particle diameter observed after SEC reflects the selective enrichment of specific EV subpopulations rather than increased variability, a phenomenon commonly reported for PDEVs. SEC also improved purity by removing protein aggregates and non-vesicular particles, yielding a stable and reproducible vesicle population suitable for functional analyses. These size and structural characteristics are consistent with previously described plant-derived EVs, including those from citrus, green tea, and aloe, which are known for their stability and ability to transport bioactive molecules [21,44,45].

3.2. In Vitro Antioxidant Capacity of Rhubarb-Derived Extracellular Vesicles

At the beginning, the antioxidant activity of rhubarb-derived EVs was analyzed through the DPPH (2,2-Diphenyl-1-picrylhydrazyl), ABTS (2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt), CUPRAC (cupric-ion-reducing antioxidant capacity), and FRAP (ferric-reducing ability of plasma) assays, in order to determine their ability to neutralize free radicals and chelate metal ions as a first-level screening tool. Moreover, the IC50 was determined by linear interpolation from the dose–response curves, representing the concentration of rhubarb-derived EVs required to reduce free radical activity by 50% in the DPPH and ABTS assays or to achieve 50% of the maximal antioxidant response in the FRAP and CUPRAC assays. The obtained values were expressed in µg of EVs per 106 particles, with standard deviations calculated from three independent experiments. Table 1 reports the results of the antioxidant capacity of rhubarb-derived EVs expressed in µmol of Trolox equivalents (TE).
The ABTS assay revealed an antioxidant capacity of 120.65 ± 6.75 µmol TE/106 particles, while the DPPH showed a slightly lower value of 92.6 ± 11.45 µmol TE/106 particles. These results indicate a broad-spectrum antioxidant activity, with a higher Trolox-equivalent antioxidant capacity detected using ABTS. On the other hand, the IC50 values, which represent the concentration required to inhibit 50% of radical activity, were 7.50 ± 0.26 µg/106 particles for ABTS and 4.5 ± 0.09 µg/106 particles for DPPH. The lower IC50 in the DPPH test indicates that the rhubarb-derived EVs contain highly potent radical scavenging compounds, which are effective in the interaction with DPPH radicals. The CUPRAC assay demonstrated an antioxidant capacity of 722.50 ± 2.30 µmol TE/106 particles, whereas the FRAP assay yielded a lower value of 342.65 ± 6.95 µmol TE/106 particles. These findings indicate that rhubarb-derived EVs exhibit important redox potential, with a greater overall electron-donating ability observed in the CUPRAC assay. In terms of IC50 values, the CUPRAC assay exhibited an IC50 of 250.80 ± 12.65 µg/106 particles, while the FRAP assay displayed a significantly lower IC50 of 31.10 ± 2.85 µg/106 particles. The lower IC50 in the FRAP assay suggests that the EVs harbor potent ferric-reducing constituents that efficiently participate in single-electron transfer reactions. In contrast, the higher IC50 in CUPRAC implies a weaker interaction with cupric ions, reflecting differences in redox potential and the mechanistic specificity of the antioxidant compounds present in rhubarb-derived EVs. These differences highlight the complexity of their antioxidant profiles and indicate the presence of heterogeneous bioactive molecules with different reduction potentials. Moreover, the magnitude of these Trolox-equivalent values is consistent with those reported for other antioxidant-rich plant-derived EVs. For example, citrus-derived EVs exhibited strong ABTS and DPPH scavenging activities with values of 369.11 ± 1.92 and 75.62 ± 0.77, respectively, which are consistent with our results [44]. Thus, these results place rhubarb-derived EVs within the range of antioxidant activities already documented for other PDEVs, supporting their classification as vesicles with a robust redox potential.

3.3. Untargeted Polyphenol Analysis Through LC/MS

To assess the presence of polyphenols in rhubarb-derived extracellular vesicles, an analysis was conducted using liquid chromatography coupled with mass spectrometry (LC-MS). Furthermore, to avoid the absence of co-contamination by polyphenols in the EV fraction, the spectrophotometric ratio A280/A230 was evaluated, obtaining a value of 1.92, which indicates a high purity of the preparation and avoids the significant presence of residual phenolic contaminants. Additionally, a semi-quantitative evaluation was performed, using the total polyphenol content (TPC) determined by the Folin method as a reference, as previously described. The analysis enabled the identification and quantification of a range of bioactive compounds, primarily polyphenols, as reported in Table 2.
Among the most abundant metabolites detected, (-)-epicatechin (4.73 µg/g), gallic acid (2.66 µg/g), and rhein (2.48 µg/g) were predominant. These polyphenols have previously been identified in extracts of rhubarb, suggesting that such secondary metabolites are actively transported through PDEVs [10]. Beyond these primary compounds, several flavonoids and proanthocyanidins with significant biological activity were also identified. Of note, procyanidin B1 (0.46 µg/g) and procyanidin B2 (0.10 µg/g) have demonstrated an antioxidant activity exceeding that of vitamin C [46]. Finally, among the identified phenolic compounds, trans-4-coumaric acid (0.20 µg/g) and naringenin (0.10 µg/g) are known modulators of antioxidant and inflammatory activity and have also been identified in other plant species [47,48]. These findings indicate that the cargo of rhubarb-derived EVs is characterized by many interesting secondary metabolites, such as polyphenols, which may have anti-inflammatory and antioxidant activity. This evidence is consistent with previous research highlighting the potential of EVs as bioactive compound carriers for therapeutic applications in neurodegenerative diseases.

3.4. Rhubarb-Derived Extracellular Vesicle Uptake

To assess the intracellular uptake of R. rhabarbarum EVs, HDF cells were incubated with DiL-labeled vesicles and analyzed by fluorescence microscopy analysis, using dye-only controls processed through the same ultracentrifugation method to exclude non-specific labeling or dye aggregation (Figure 2).
Following exposure, a distinct red fluorescence signal was detected within the cytoplasmic region of the HDF AD cells, indicating that the rhubarb-derived vesicles were efficiently taken up by the cells rather than remaining attached to the cell surface. The fluorescence pattern appeared as punctate spots distributed throughout the cytoplasm, consistent with vesicular localization, and suggesting the accumulation of EVs within intracellular compartments. No fluorescence was detected in cells incubated with the extraction buffer processed through the same differential centrifugation and DiL-labeling procedure, confirming the specificity of the observed signal.

3.5. Intracellular Antioxidant Activity of Rhubarb-Derived EVs

To investigate the biological activity of rhubarb-derived EVs after their uptake and the potential protective effect on AD cells, several studies were performed to assess the cytotoxicity, oxidative stress level, the expression of key oxidative stress-related protein markers, and cellular energy metabolism (Figure 3).
To assess the potential cytotoxicity of rhubarb-derived EVs, an MTT cell viability assay was performed on both control (CTRL) and AD cells treated with different EV concentrations, expressed as particles per million. As shown in Figure 3a, EV treatment did not compromise cell viability at any of the tested concentrations in both cell types. On the contrary, a slight increase in viability was observed, suggesting a potential stimulatory effect on cell growth at specific concentrations. These results were further confirmed by the Trypan blue exclusion assay, which showed that the tested concentrations of EVs were not cytotoxic for the analyzed cell lines (Figure S3). Moreover, in order to demonstrate the antioxidant effect of rhubarb-derived EVs, the basal levels of ROS produced by CTRL and AD cells and those produced by AD cells treated with high concentrations of EVs (1.10 × 106 particles) were evaluated. In fact, one of the key pathological mechanisms in AD is increased oxidative stress, characterized by excessive production of ROS. As shown in Figure 3b, AD cells exhibited a significant increase in ROS levels compared to CTRL cells (p < 0.0001), indicating a pronounced oxidative imbalance. However, EV treatment resulted in a drastic reduction in ROS production and restoration to levels comparable to control cells. In addition, in order to exclude non-specific quenching by phenolic compounds present in the EVs, a cell-free control was performed in which EVs were incubated with the ROS-sensitive fluorescent probe in the absence of cells. No significant decrease in fluorescence was observed, indicating that the effect measured in cells reflects a true reduction in ROS. To further investigate the antioxidant effects of EVs, the expression levels of key oxidative stress response enzymes—catalase, SOD1, and COX—were analyzed (Figure 3c). AD cells exhibited an upregulation of SOD1 and catalase, compared to CTRL cells (p < 0.05 and p < 0.01, respectively), which is likely reflecting an adaptive response to oxidative damage. However, EV treatment reduced the expression of oxidative markers, suggesting a decrease in oxidative challenge rather than a direct modulation of antioxidant pathways, and indicating a reduced requirement for compensatory cellular defense mechanisms. Similarly, COX expression was elevated in AD cells, which may be associated with altered mitochondrial activity, whereas EV treatment led to a reduction in COX levels, consistent with a functional attenuation of mitochondrial stress. Finally, the impact of rhubarb-derived EVs on cellular energy metabolism was investigated through a Seahorse Glycolytic Rate Assay to assess total glycolytic activity (GlycoPER), basal glycolysis (Basal GlycoPER), and compensatory glycolysis (Compensatory GlycoPER) (Figure 3d). The GlycoPER value was calculated by excluding the mitochondrial contribution to the Proton Efflux Rate (PER), which was determined using Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) measurements. The results indicate that AD cells exhibit a significant increase in GlycoPER compared to control cells (p < 0.01), suggesting a metabolic shift towards glycolysis as a compensatory mechanism for mitochondrial dysfunction. Both Basal GlycoPER and Compensatory GlycoPER also significantly increased, reflecting an overall intensification in glycolytic activity and an enhanced ability of AD cells to compensate for metabolic imbalances. Particularly, treatment with rhubarb-derived EVs led to a significant reduction in all analyzed parameters (p < 0.001), indicating a functional rebalancing of cellular energy metabolism and reduced dependence on glycolytic flux, without implying direct restoration of mitochondrial bioenergetics.

4. Discussion

Oxidative stress is one of the most widely studied cellular stressors, as it interferes with normal cellular functions and contributes to a variety of pathological conditions [49,50]. It is central to the onset and progression of many degenerative diseases, including neurodegenerative diseases (such as Alzheimer’s and Parkinson’s), cancer, and cardiovascular disease [50,51]. Given its widespread impact, the search for natural compounds with antioxidant properties has gained increasing attention as a potential strategy for disease prevention and therapy. In this study, the properties of EVs derived from edible R. rhabarbarum rhizome, focusing on their structural characteristics, antioxidant potential, and biological effects, have been explored in order to investigate their ability to modulate oxidative stress and energy metabolism in an in vitro model of neurodegeneration, providing new insights into their potential therapeutic applications.
Rhubarb-derived EVs were morphologically characterized using Scanning Electron Microscopy (SEM) and nanoparticle tracking analysis (NTA), revealing a population of vesicles with an average size of approximately 144.6 nm and a total yield of about 4.4 × 109 particles per gram of rhizome. These size and structural characteristics are consistent with previously described plant-derived EVs, including those from citrus, green tea, and aloe, which are known for their stability and ability to transport bioactive molecules [21,44,45]. One of the most significant aspects of this study is the high antioxidant potential of rhubarb EVs, as demonstrated by in vitro assays (DPPH, ABTS, FRAP, and CUPRAC). Specifically, the EVs exhibited a strong free radical scavenging capacity, with IC50 values of 7.50 µg/106 particles in the ABTS assay and 4.50 µg/106 particles in the DPPH assay, indicating the presence of potent antioxidant compounds. These findings are comparable to those reported for polyphenol-rich extracellular vesicles from other plant species [52,53,54]. Moreover, the redox capacity detected in the CUPRAC and FRAP assays suggests that bioactive compounds contained within the EVs may exert protective effects through electron transfer mechanisms. The antioxidant values obtained are comparable to previously published data on plant-derived EVs [44,52]. These comparisons support the interpretation that the antioxidant profile of rhubarb-derived EVs aligns with the stronger antioxidant PDEVs described in the literature. In agreement with these biochemical properties, the metabolic profiling of rhubarb-derived EVs revealed the presence of a lot of interesting polyphenols, including (-)-epicatechin and gallic acid, which have previously been identified in extracts of R. rhabarbarum [10]. These secondary metabolites are well-documented for their potent antioxidant and anti-inflammatory activities, with evidence suggesting their neuroprotective effects in preclinical models of Alzheimer’s disease through mechanisms such as attenuation of oxidative damage, inhibition of amyloid-β aggregation, and modulation of signaling pathways involved in neuronal survival [55,56,57]. (-)-Epicatechin, a flavanol recognized for its neuroprotective and antioxidant properties, has been shown in preclinical studies to enhance endothelial function and mitigate oxidative damage in neurons, thereby modulating cellular stress [58,59]. Similarly, gallic acid, a phenolic acid with anti-inflammatory and neuroprotective effects, is capable of reducing reactive oxygen species (ROS) production and promoting neuronal survival in neurodegenerative disease models [60,61,62]. Rhein, an anthraquinone derivative, has been linked to beneficial effects on mitochondrial metabolism and autophagy regulation, with potential neuroprotective implications in conditions such as Alzheimer’s disease [63,64]. The detection of these polyphenols in rhubarb-derived EVs indicates their potential role as molecular cargo, supporting the hypothesis that plant-derived extracellular vesicles can act as natural nanocarriers for bioactive metabolites with therapeutic implications in neurodegenerative disorders. From a biological perspective, this study aims to evaluate the effects of EVs in a cellular model of AD. In particular, the present study employed human dermal fibroblasts derived from AD donors, a peripheral cellular model frequently used to investigate systemic alterations associated with AD. While fibroblasts cannot reproduce neuronal dysfunction, they exhibit mitochondrial impairment, increased ROS production, deficits in antioxidant systems, and metabolic alterations that mirror early systemic changes occurring in AD [65,66,67]. The MTT assay confirmed the absence of cytotoxic effects and the ability of rhubarb-derived EVs to reduce ROS levels in AD cells. Specifically, EV treatment significantly decreased ROS levels, restoring them to values comparable to those observed in control cells. This suggests a potential neuroprotective effect, likely mediated by bioactive molecules such as polyphenols and flavonoids, which are known for their antioxidant properties and have been reported in other plant-derived EV studies [21,52,68,69,70,71,72].
At the molecular level, the modulation of key antioxidant enzyme expression, specifically catalase and SOD1, further supports the role of rhubarb-derived EVs in oxidative stress regulation. The elevated levels of catalase and SOD1 in untreated AD cells indicate a compensatory response to chronic oxidative stress, a mechanism previously described in cellular and murine models of neurodegeneration [73]. However, EV treatment significantly reduced the expression of these enzymes, suggesting a normalization of intracellular redox balance and a reduced need for endogenous antioxidant defense activation. Another novel aspect of this study is the ability of rhubarb-derived EVs to modulate energy metabolism in AD cells. Glycolytic Rate analysis revealed a significant increase in glycolysis in AD cells compared to controls, indicative of a compensatory response to mitochondrial dysfunction, an extensively documented phenomenon in AD pathophysiology [74]. EV treatment led to a marked reduction in total glycolysis (GlycoPER), basal glycolysis (Basal GlycoPER), and compensatory glycolysis (Compensatory GlycoPER), indicating an association between EV exposure and metabolic rebalancing in this cellular model. This observation is particularly relevant given that bioenergetic dysfunction is considered an early event in AD progression and is increasingly recognized as a promising therapeutic target [75]. Overall, these findings suggest that rhubarb-derived EVs may act as modulators of oxidative stress and energy metabolism in AD cells, providing new insights into their potential therapeutic applications. In particular, their ability to reduce ROS levels and restore glycolytic balance strengthens the hypothesis of their neuroprotective properties. However, as these are preliminary in vitro studies, further in vivo investigations and cargo-specific analyses are required to confirm their efficacy and to elucidate their therapeutic potential.

5. Conclusions

Plant-derived extracellular vesicles have emerged as promising and versatile tools in biomedical research due to their ability to encapsulate, protect, and transport bioactive compounds that can interact with animal cells. The results of this study suggest that rhubarb-derived EVs may contribute to the regulation of oxidative stress and metabolic dysfunction, both of which are critical factors in the pathophysiology of Alzheimer’s disease. Moreover, these EVs are obtained from edible plant material, which highlights their potential as safe, naturally derived nutraceutical agents that could be directly incorporated into the diet or developed into functional food products. The consumption of rhubarb-derived EVs may represent a novel strategy to deliver bioactive compounds in a biocompatible and non-toxic form, overcoming some of the limitations associated with synthetic nanocarriers. Nonetheless, as these findings derive from preliminary in vitro experiments, further investigations are needed to confirm these effects and completely assess the therapeutic and nutraceutical potential of rhubarb-derived EVs.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/nu17233771/s1, Figure S1. Analysis of Rheum rhabarbarum EVs by Dynamic Light Scattering (DLS) in order to evaluate the zeta potential. The zeta potential value was obtained after multiple analysis cycles for a total of 13 minutes of evaluation. Figure S2. Nanoparticle tracking analysis of Rheum rhabarbarum EV fractions obtained by SEC. Evaluation of particle size and concentration of different density gradient fractions (from 4 to 12) is reported as particles/mL obtained by NTA. Figure S3. Trypan blue exclusion assay on CTRL and AD cells treated with the same concentrations of EVs, tested with MTT assay, in order to evaluate the potential cytotoxicity. Data are expressed as mean ± SD of three replicates.

Author Contributions

Conceptualization, E.C. and C.E.; methodology, E.C., G.C., A.B. and G.Z.; validation, S.B. and L.U.; formal analysis, E.C., G.C., A.B. and H.B.R.A.; investigation, E.C., G.C., A.B., H.B.R.A. and R.M.P.; resources, C.E.; data curation, E.C., G.C., A.B. and G.Z.; writing—original draft preparation, E.C.; writing—review and editing, E.C., G.C., A.B., H.B.R.A., R.M.P., S.B., L.U., G.Z. and C.E.; visualization, E.C., G.C. and A.B.; supervision, C.E., S.B. and L.U.; project administration, C.E.; funding acquisition, C.E. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the European Union—NextGenerationEU under the Italian Ministry of University and Research (MUR) National Innovation Ecosystem grant ECS00000041—VITALITY—CUP J97G22000170005 (to Carla Emiliani).

Institutional Review Board Statement

This study was approved by the University of Perugia Ethics Committee with approval number Prot. N. CE-2492/25 (7/23/2025).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The original contributions presented in this study are included in the article/Supplementary Materials. Further inquiries can be directed to the corresponding authors.

Acknowledgments

We thank the University of Perugia and the Italian Ministry of University and Research (MUR) for their support within the VITALITY project.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ADAlzheimer’s Disease
PDEVsPlant-Derived Extracellular Vesicles
EVsExtracellular Vesicles
SEMScanning Electron Microscopy
NTANanoparticle Tracking Analysis
DPPH2,2-Diphenyl-1-picrylhydrazyl
ABTS2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
FRAPFerric-Reducing Antioxidant Power
CUPRACCupric-Ion-Reducing Antioxidant Capacity
ROSReactive Oxygen Species
TEsTrolox Equivalents
TPCTotal Polyphenol Content
SOD1Superoxide Dismutase 1
COXCyclooxygenase
GlycoPERGlycolytic Proton Efflux Rate
OCROxygen Consumption Rate
ECARExtracellular Acidification Rate

References

  1. Sun, X.; Li, X. Editorial: Aging and Chronic Disease: Public Health Challenge and Education Reform. Front. Public. Health 2023, 11, 1175898. [Google Scholar] [CrossRef]
  2. Keshavarzi, Z.; Shakeri, F.; Maghool, F.; Jamialahmadi, T.; Johnston, T.P.; Sahebkar, A. A Review on the Phytochemistry, Pharmacology, and Therapeutic Effects of Rheum Ribes. In Natural Products and Human Diseases: Pharmacology, Molecular Targets, and Therapeutic Benefits; Sahebkar, A., Sathyapalan, T., Eds.; Springer International Publishing: Cham, Switzerland, 2021; pp. 447–461. ISBN 978-3-030-73234-9. [Google Scholar]
  3. Thakur, M. Rhubarb (Rheum Sp.): A Rare and Endangered Medicinal Plant of the Himalayas. In Advances in Medicinal and Aromatic Plants; Apple Academic Press: Oakville, ON, USA, 2024; ISBN 978-1-032-68690-5. [Google Scholar]
  4. Ma, C.; Yang, L.; Degen, A.A.; Ding, L. The Water Extract of Rheum. Palmatum Has Antioxidative Properties and Inhibits ROS Production in Mice. J. Ethnopharmacol. 2024, 335, 118602. [Google Scholar] [CrossRef]
  5. Wen, Y.; Yan, P.-J.; Fan, P.-X.; Lu, S.-S.; Li, M.-Y.; Fu, X.-Y.; Wei, S.-B. The Application of Rhubarb Concoctions in Traditional Chinese Medicine and Its Compounds, Processing Methods, Pharmacology, Toxicology and Clinical Research. Front. Pharmacol. 2024, 15, 1442297. [Google Scholar] [CrossRef]
  6. Kolodziejczyk-Czepas, J.; Liudvytska, O. Rheum Rhaponticum and Rheum Rhabarbarum: A Review of Phytochemistry, Biological Activities and Therapeutic Potential. Phytochem. Rev. 2021, 20, 589–607. [Google Scholar] [CrossRef]
  7. Liudvytska, O.; Bandyszewska, M.; Skirecki, T.; Krzyżanowska-Kowalczyk, J.; Kowalczyk, M.; Kolodziejczyk-Czepas, J. Anti-Inflammatory and Antioxidant Actions of Extracts from Rheum. Rhaponticum and Rheum. Rhabarbarum in Human Blood Plasma and Cells in Vitro. Biomed. Pharmacother. 2023, 165, 115111. [Google Scholar] [CrossRef]
  8. Shahrajabian, M.H.; Cheng, Q.; Sun, W. Wonderful Natural Drugs with Surprising Nutritional Values, Rheum Species, Gifts of the Nature. Lett. Org. Chem. 2022, 19, 818–826. [Google Scholar] [CrossRef]
  9. Bhat, R. Bioactive Compounds of Rhubarb (Rheum Species). In Bioactive Compounds in Underutilized Vegetables and Legumes; Murthy, H.N., Paek, K.Y., Eds.; Springer International Publishing: Cham, Switzerland, 2021; pp. 239–254. ISBN 978-3-030-57415-4. [Google Scholar]
  10. Kalisz, S.; Oszmiański, J.; Kolniak-Ostek, J.; Grobelna, A.; Kieliszek, M.; Cendrowski, A. Effect of a Variety of Polyphenols Compounds and Antioxidant Properties of Rhubarb (Rheum. Rhabarbarum). LWT 2020, 118, 108775. [Google Scholar] [CrossRef]
  11. Shang, X.; Dai, L.; He, J.; Yang, X.; Wang, Y.; Li, B.; Zhang, J.; Pan, H.; Gulnaz, I. A High-Value-Added Application of the Stems of Rheum. Palmatum L. as a Healthy Food: The Nutritional Value, Chemical Composition, and Anti-Inflammatory and Antioxidant Activities. Food Funct. 2022, 13, 4901–4913. [Google Scholar] [CrossRef] [PubMed]
  12. Ambrosone, A.; Barbulova, A.; Cappetta, E.; Cillo, F.; De Palma, M.; Ruocco, M.; Pocsfalvi, G. Plant Extracellular Vesicles: Current Landscape and Future Directions. Plants 2023, 12, 4141. [Google Scholar] [CrossRef]
  13. Calzoni, E.; Bertoldi, A.; Cusumano, G.; Buratta, S.; Urbanelli, L.; Emiliani, C. Plant-Derived Extracellular Vesicles: Natural Nanocarriers for Biotechnological Drugs. Processes 2024, 12, 2938. [Google Scholar] [CrossRef]
  14. Rutter, B.D.; Innes, R.W. Extracellular Vesicles Isolated from the Leaf Apoplast Carry Stress-Response Proteins. Plant Physiol. 2017, 173, 728–741. [Google Scholar] [CrossRef]
  15. Zhou, Q.; Ma, K.; Hu, H.; Xing, X.; Huang, X.; Gao, H. Extracellular Vesicles: Their Functions in Plant–Pathogen Interactions. Mol. Plant Pathol. 2022, 23, 760–771. [Google Scholar] [CrossRef]
  16. Cai, Q.; Halilovic, L.; Shi, T.; Chen, A.; He, B.; Wu, H.; Jin, H. Extracellular Vesicles: Cross-Organismal RNA Trafficking in Plants, Microbes, and Mammalian Cells. Extracell. Vesicles Circ. Nucl. Acids 2023, 4, 262–282. [Google Scholar] [CrossRef]
  17. Kim, M.; Jang, H.; Kim, W.; Kim, D.; Park, J.H. Therapeutic Applications of Plant-Derived Extracellular Vesicles as Antioxidants for Oxidative Stress-Related Diseases. Antioxidants 2023, 12, 1286. [Google Scholar] [CrossRef] [PubMed]
  18. Lo, K.-J.; Wang, M.-H.; Ho, C.-T.; Pan, M.-H. Plant-Derived Extracellular Vesicles: A New Revolutionization of Modern Healthy Diets and Biomedical Applications. J. Agric. Food Chem. 2024, 72, 2853–2878. [Google Scholar] [CrossRef]
  19. Fan, S.-J.; Chen, J.-Y.; Tang, C.-H.; Zhao, Q.-Y.; Zhang, J.-M.; Qin, Y.-C. Edible Plant Extracellular Vesicles: An Emerging Tool for Bioactives Delivery. Front. Immunol. 2022, 13, 1028418. [Google Scholar] [CrossRef]
  20. Buratta, S.; Latella, R.; Chiaradia, E.; Salzano, A.M.; Tancini, B.; Pellegrino, R.M.; Urbanelli, L.; Cerrotti, G.; Calzoni, E.; Alabed, H.B.R.; et al. Characterization of Nanovesicles Isolated from Olive Vegetation Water. Foods 2024, 13, 835. [Google Scholar] [CrossRef] [PubMed]
  21. Calzoni, E.; Bertoldi, A.; Cesaretti, A.; Alabed, H.B.R.; Cerrotti, G.; Pellegrino, R.M.; Buratta, S.; Urbanelli, L.; Emiliani, C. Aloe Extracellular Vesicles as Carriers of Photoinducible Metabolites Exhibiting Cellular Phototoxicity. Cells 2024, 13, 1845. [Google Scholar] [CrossRef]
  22. Fang, Z.; Liu, K. Plant-Derived Extracellular Vesicles as Oral Drug Delivery Carriers. J. Control. Release 2022, 350, 389–400. [Google Scholar] [CrossRef]
  23. Zhou, S.; Cao, Y.; Shan, F.; Huang, P.; Yang, Y.; Liu, S. Analyses of Chemical Components and Their Functions in Single Species Plant-Derived Exosome like Vesicle. TrAC Trends Anal. Chem. 2023, 167, 117274. [Google Scholar] [CrossRef]
  24. Jurcău, M.C.; Andronie-Cioara, F.L.; Jurcău, A.; Marcu, F.; Ţiț, D.M.; Pașcalău, N.; Nistor-Cseppentö, D.C. The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives. Antioxidants 2022, 11, 2167. [Google Scholar] [CrossRef] [PubMed]
  25. González-Reyes, R.E.; Nava-Mesa, M.O.; Vargas-Sánchez, K.; Ariza-Salamanca, D.; Mora-Muñoz, L. Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective. Front. Mol. Neurosci. 2017, 10, 427. [Google Scholar] [CrossRef]
  26. Jalouli, M.; Rahman, M.A.; Biswas, P.; Rahman, H.; Harrath, A.H.; Lee, I.-S.; Kang, S.; Choi, J.; Park, M.N.; Kim, B. Targeting Natural Antioxidant Polyphenols to Protect Neuroinflammation and Neurodegenerative Diseases: A Comprehensive Review. Front. Pharmacol. 2025, 16, 1492517. [Google Scholar] [CrossRef]
  27. Kruszka, J.; Martyński, J.; Szewczyk-Golec, K.; Woźniak, A.; Nuszkiewicz, J. The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential. Brain Sci. 2025, 15, 485. [Google Scholar] [CrossRef] [PubMed]
  28. Nájera-Maldonado, J.M.; Salazar, R.; Alvarez-Fitz, P.; Acevedo-Quiroz, M.; Flores-Alfaro, E.; Hernández-Sotelo, D.; Espinoza-Rojo, M.; Ramírez, M. Phenolic Compounds of Therapeutic Interest in Neuroprotection. J. Xenobiotics 2024, 14, 227–246. [Google Scholar] [CrossRef]
  29. WMA. The World Medical Association-WMA Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Participants. JAMA 2025, 333, 71–74. [Google Scholar] [CrossRef]
  30. Chiaradia, E.; Tancini, B.; Emiliani, C.; Delo, F.; Pellegrino, R.M.; Tognoloni, A.; Urbanelli, L.; Buratta, S. Extracellular Vesicles under Oxidative Stress Conditions: Biological Properties and Physiological Roles. Cells 2021, 10, 1763. [Google Scholar] [CrossRef] [PubMed]
  31. Bradford, M.M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976, 72, 248–254. [Google Scholar] [CrossRef]
  32. Blois, M.S. Antioxidant Determinations by the Use of a Stable Free Radical. Nature 1958, 181, 1199–1200. [Google Scholar] [CrossRef]
  33. Miller, N.J.; Rice-Evans, C.; Davies, M.J.; Gopinathan, V.; Milner, A. A Novel Method for Measuring Antioxidant Capacity and Its Application to Monitoring the Antioxidant Status in Premature Neonates. Clin. Sci. 1993, 84, 407–412. [Google Scholar] [CrossRef]
  34. Harrabi, B.; Ben Nasr, H.; Amri, Z.; Brahmi, F.; El Feki, A.; Zeghal, K.; Ghozzi, H.; Siddiqui, A.J.; Adnan, M.; Aloufi, B.; et al. Chemical Composition, Nutritional Value, Antioxidative, and In Vivo Anti-Inflammatory Activities of Opuntia Stricta Cladode. ACS Omega 2024, 9, 26724–26734. [Google Scholar] [CrossRef]
  35. Apak, R.; Güçlü, K.; Özyürek, M.; Karademi˙r, S.E.; Altun, M. Total Antioxidant Capacity Assay of Human Serum Using Copper(II)-Neocuproine as Chromogenic Oxidant: The CUPRAC Method. Free Radic. Res. 2005, 39, 949–961. [Google Scholar] [CrossRef]
  36. Benzie, I.F.F.; Strain, J.J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Anal. Biochem. 1996, 239, 70–76. [Google Scholar] [CrossRef]
  37. Ainsworth, E.A.; Gillespie, K.M. Estimation of Total Phenolic Content and Other Oxidation Substrates in Plant Tissues Using Folin–Ciocalteu Reagent. Nat. Protoc. 2007, 2, 875–877. [Google Scholar] [CrossRef]
  38. Alabed, H.B.R.; Pellegrino, R.M.; Buratta, S.; Lema Fernandez, A.G.; La Starza, R.; Urbanelli, L.; Mecucci, C.; Emiliani, C.; Gorello, P. Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup. Int. J. Mol. Sci. 2024, 25, 3921. [Google Scholar] [CrossRef] [PubMed]
  39. Calzoni, E.; Cesaretti, A.; Montegiove, N.; Valicenti, M.L.; Morena, F.; Misra, R.; Carlotti, B.; Martino, S. Phenothiazine-Based Nanoaggregates: Dual Role in Bioimaging and Stem Cell-Driven Photodynamic Therapy. Nanomaterials 2025, 15, 894. [Google Scholar] [CrossRef] [PubMed]
  40. Laemmli, U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 1970, 227, 680–685. [Google Scholar] [CrossRef] [PubMed]
  41. Sakamuri, S.S.V.P.; Sure, V.N.; Kolli, L.; Liu, N.; Evans, W.R.; Sperling, J.A.; Busija, D.W.; Wang, X.; Lindsey, S.H.; Murfee, W.L.; et al. Glycolytic and Oxidative Phosphorylation Defects Precede the Development of Senescence in Primary Human Brain Microvascular Endothelial Cells. GeroScience 2022, 44, 1975–1994. [Google Scholar] [CrossRef]
  42. Jin, J.; Qiu, S.; Wang, P.; Liang, X.; Huang, F.; Wu, H.; Zhang, B.; Zhang, W.; Tian, X.; Xu, R.; et al. Cardamonin Inhibits Breast Cancer Growth by Repressing HIF-1α-Dependent Metabolic Reprogramming. J. Exp. Clin. Cancer Res. 2019, 38, 377. [Google Scholar] [CrossRef]
  43. Webber, J.; Clayton, A. How Pure Are Your Vesicles? J. Extracell. Vesicles 2013, 2, 19861. [Google Scholar] [CrossRef]
  44. Li, S.; Ye, Z.; Zhao, L.; Yao, Y.; Zhou, Z. Evaluation of Antioxidant Activity and Drug Delivery Potential of Cell-Derived Extracellular Vesicles from Citrus Reticulata Blanco Cv. ‘Dahongpao’. Antioxidants 2023, 12, 1706. [Google Scholar] [CrossRef] [PubMed]
  45. Gonzalez Suarez, N.; Fernandez-Marrero, Y.; Hébert, M.P.A.; Roy, M.-E.; Boudreau, L.H.; Annabi, B. EGCG Inhibits the Inflammation and Senescence Inducing Properties of MDA-MB-231 Triple-Negative Breast Cancer (TNBC) Cells-Derived Extracellular Vesicles in Human Adipose-Derived Mesenchymal Stem Cells. Cancer Cell Int. 2023, 23, 240. [Google Scholar] [CrossRef]
  46. Chen, J.; Chen, Y.; Zheng, Y.; Zhao, J.; Yu, H.; Zhu, J. The Relationship between Procyanidin Structure and Their Protective Effect in a Parkinson’s Disease Model. Molecules 2022, 27, 5007. [Google Scholar] [CrossRef]
  47. Nie, C.; Li, T.; Fan, M.; Wang, Y.; Sun, Y.; He, R.; Zhang, X.; Qian, H.; Ying, H.; Wang, L.; et al. Polyphenols in Highland Barley Tea Inhibit the Production of Advanced Glycosylation End-Products and Alleviate the Skeletal Muscle Damage. Mol. Nutr. Food Res. 2022, 66, 2200225. [Google Scholar] [CrossRef]
  48. Kagawa, N.; Iguchi, H.; Henzan, M.; Hanaoka, M. Drying the Leaves of Perilla Frutescens Increases Their Content of Anticancer Nutraceuticals. Food Sci. Nutr. 2019, 7, 1494–1501. [Google Scholar] [CrossRef]
  49. Bibi Sadeer, N.; Montesano, D.; Albrizio, S.; Zengin, G.; Mahomoodally, M.F. The Versatility of Antioxidant Assays in Food Science and Safety—Chemistry, Applications, Strengths, and Limitations. Antioxidants 2020, 9, 709. [Google Scholar] [CrossRef]
  50. Domanskyi, A.; Parlato, R. Oxidative Stress in Neurodegenerative Diseases. Antioxidants 2022, 11, 504. [Google Scholar] [CrossRef]
  51. Ginckels, P.; Holvoet, P. Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-Coding RNAs. Yale J. Biol. Med. 2022, 95, 129–152. [Google Scholar]
  52. Perut, F.; Roncuzzi, L.; Avnet, S.; Massa, A.; Zini, N.; Sabbadini, S.; Giampieri, F.; Mezzetti, B.; Baldini, N. Strawberry-Derived Exosome-Like Nanoparticles Prevent Oxidative Stress in Human Mesenchymal Stromal Cells. Biomolecules 2021, 11, 87. [Google Scholar] [CrossRef] [PubMed]
  53. Charoensedtasin, K.; Norkaew, C.; Naksawat, M.; Kheansaard, W.; Roytrakul, S.; Tanyong, D. Anticancer Effects of Pomegranate-Derived Peptide PG2 on CDK2 and miRNA-339-5p-Mediated Apoptosis via Extracellular Vesicles in Acute Leukemia. Sci. Rep. 2024, 14, 27367. [Google Scholar] [CrossRef] [PubMed]
  54. Chintapula, U.; Oh, D.; Perez, C.; Davis, S.; Ko, J. Anti-Cancer Bioactivity of Sweet Basil Leaf Derived Extracellular Vesicles on Pancreatic Cancer Cells. J. Extracell. Biol. 2024, 3, e142. [Google Scholar] [CrossRef]
  55. Thapa, R.; Gupta, G.; Dave, P.; Singh, S.K.; Raizaday, A.; Almalki, W.H.; Vyas, G.; Singh, S.K.; Dua, K.; Singh, Y. Current Update on the Protective Effect of Epicatechin in Neurodegenerative Diseases. EXCLI J. 2022, 21, 897–903. [Google Scholar] [CrossRef]
  56. Ferruzzi, M.G.; Lobo, J.K.; Janle, E.M.; Cooper, B.; Simon, J.E.; Wu, Q.-L.; Welch, C.; Ho, L.; Weaver, C.; Pasinetti, G.M. Bioavailability of Gallic Acid and Catechins from Grape Seed Polyphenol Extract Is Improved by Repeated Dosing in Rats: Implications for Treatment in Alzheimer’s Disease. J. Alzheimers Dis. 2009, 18, 113–124. [Google Scholar] [CrossRef]
  57. Kundo, N.K.; Manik, M.I.N.; Biswas, K.; Khatun, R.; Al-Amin, M.Y.; Alam, A.H.M.K.; Tanaka, T.; Sadik, G. Identification of Polyphenolics from Loranthus Globosus as Potential Inhibitors of Cholinesterase and Oxidative Stress for Alzheimer’s Disease Treatment. BioMed Res. Int. 2021, 2021, 9154406. [Google Scholar] [CrossRef]
  58. Harahap, U.; Syahputra, R.A.; Ahmed, A.; Nasution, A.; Wisely, W.; Sirait, M.L.; Dalimunthe, A.; Zainalabidin, S.; Taslim, N.A.; Nurkolis, F.; et al. Current Insights and Future Perspectives of Flavonoids: A Promising Antihypertensive Approach. Phytother. Res. 2024, 38, 3146–3168. [Google Scholar] [CrossRef]
  59. Bondonno, C.P.; Yang, X.; Croft, K.D.; Considine, M.J.; Ward, N.C.; Rich, L.; Puddey, I.B.; Swinny, E.; Mubarak, A.; Hodgson, J.M. Flavonoid-Rich Apples and Nitrate-Rich Spinach Augment Nitric Oxide Status and Improve Endothelial Function in Healthy Men and Women: A Randomized Controlled Trial. Free Radic. Biol. Med. 2012, 52, 95–102. [Google Scholar] [CrossRef] [PubMed]
  60. Huang, J.; Wu, F.; Cao, W.; Chen, Y.; Yao, Q.; Cen, P.; Wang, J.; Hong, L.; Zhang, X.; Zhou, R.; et al. Ultrasmall Iron-Gallic Acid Coordination Polymer Nanoparticles for Scavenging ROS and Suppressing Inflammation in Tauopathy-Induced Alzheimer’s Disease. Biomaterials 2025, 317, 123042. [Google Scholar] [CrossRef] [PubMed]
  61. Obafemi, T.O.; Ekundayo, B.E.; Adewale, O.B.; Obafemi, B.A.; Anadozie, S.O.; Adu, I.A.; Onasanya, A.O.; Ekundayo, S.K. Gallic Acid and Neurodegenerative Diseases. Phytomedicine Plus 2023, 3, 100492. [Google Scholar] [CrossRef]
  62. Sun, J.; Li, Y.; Ding, Y.; Wang, J.; Geng, J.; Yang, H.; Ren, J.; Tang, J.; Gao, J. Neuroprotective Effects of Gallic Acid against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunctions in Vitro and Cerebral Ischemia/Reperfusion Injury in Vivo. Brain Res. 2014, 1589, 126–139. [Google Scholar] [CrossRef]
  63. Yin, Z.; Geng, X.; Zhang, Z.; Wang, Y.; Gao, X. Rhein Relieves Oxidative Stress in an Aβ1-42 Oligomer-Burdened Neuron Model by Activating the SIRT1/PGC-1α-Regulated Mitochondrial Biogenesis. Front. Pharmacol. 2021, 12, 746711. [Google Scholar] [CrossRef]
  64. Yin, Z.; Gao, D.; Du, K.; Han, C.; Liu, Y.; Wang, Y.; Gao, X. Rhein Ameliorates Cognitive Impairment in an APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease by Relieving Oxidative Stress through Activating the SIRT1/PGC-1α Pathway. Oxidative Med. Cell. Longev. 2022, 2022, 2524832. [Google Scholar] [CrossRef]
  65. Ramamoorthy, M.; Sykora, P.; Scheibye-Knudsen, M.; Dunn, C.; Kasmer, C.; Zhang, Y.; Becker, K.G.; Croteau, D.L.; Bohr, V.A. Sporadic Alzheimer Disease Fibroblasts Display an Oxidative Stress Phenotype. Free Radic. Biol. Med. 2012, 53, 1371–1380. [Google Scholar] [CrossRef]
  66. Cecchi, C.; Fiorillo, C.; Sorbi, S.; Latorraca, S.; Nacmias, B.; Bagnoli, S.; Nassi, P.; Liguri, G. Oxidative Stress and Reduced Antioxidant Defenses in Peripheral Cells from Familial Alzheimer’s Patients. Free Radic. Biol. Med. 2002, 33, 1372–1379. [Google Scholar] [CrossRef]
  67. Ibáñez-Salazar, A.; Bañuelos-Hernández, B.; Rodríguez-Leyva, I.; Chi-Ahumada, E.; Monreal-Escalante, E.; Jiménez-Capdeville, M.E.; Rosales-Mendoza, S. Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts. Front. Neurosci. 2017, 11, 495. [Google Scholar] [CrossRef]
  68. Misrani, A.; Tabassum, S.; Yang, L. Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease. Front. Aging Neurosci. 2021, 13, 617588. [Google Scholar] [CrossRef]
  69. Angelova, P.R.; Esteras, N.; Abramov, A.Y. Mitochondria and Lipid Peroxidation in the Mechanism of Neurodegeneration: Finding Ways for Prevention. Med. Res. Rev. 2021, 41, 770–784. [Google Scholar] [CrossRef]
  70. Shkryl, Y.; Tsydeneshieva, Z.; Menchinskaya, E.; Rusapetova, T.; Grishchenko, O.; Mironova, A.; Bulgakov, D.; Gorpenchenko, T.; Kazarin, V.; Tchernoded, G.; et al. Exosome-like Nanoparticles, High in Trans-δ-Viniferin Derivatives, Produced from Grape Cell Cultures: Preparation, Characterization, and Anticancer Properties. Biomedicines 2024, 12, 2142. [Google Scholar] [CrossRef] [PubMed]
  71. Trentini, M.; Zanolla, I.; Zanotti, F.; Tiengo, E.; Licastro, D.; Dal Monego, S.; Lovatti, L.; Zavan, B. Apple Derived Exosomes Improve Collagen Type I Production and Decrease MMPs during Aging of the Skin through Downregulation of the NF-κB Pathway as Mode of Action. Cells 2022, 11, 3950. [Google Scholar] [CrossRef] [PubMed]
  72. Addi, M.; Elbouzidi, A.; Abid, M.; Tungmunnithum, D.; Elamrani, A.; Hano, C. An Overview of Bioactive Flavonoids from Citrus Fruits. Appl. Sci. 2022, 12, 29. [Google Scholar] [CrossRef]
  73. Olufunmilayo, E.O.; Gerke-Duncan, M.B.; Holsinger, R.M.D. Oxidative Stress and Antioxidants in Neurodegenerative Disorders. Antioxidants 2023, 12, 517. [Google Scholar] [CrossRef] [PubMed]
  74. Zhang, X.; Alshakhshir, N.; Zhao, L. Glycolytic Metabolism, Brain Resilience, and Alzheimer’s Disease. Front. Neurosci. 2021, 15, 662242. [Google Scholar] [CrossRef] [PubMed]
  75. Wilkins, H.M.; Carl, S.M.; Greenlief, A.C.S.; Festoff, B.W.; Swerdlow, R.H. Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection. Front. Aging Neurosci. 2014, 6, 311. [Google Scholar] [CrossRef] [PubMed]
Figure 1. SEM images (a) and NTA (b) of the rhubarb-enriched fraction of EVs. Particle distribution obtained by NTA on EV SEC fractions and NTA of fractions 7 and 8 with the ratio of the particle number per μg of the protein that is indicative of the protein enrichment of each EV isolation by SEC (c), with TET8 and Calnexin detection in enriched fractions (E.Fr) of EVs and Fr. 7 and Fr. 8 obtained by SEC and R. rhabarbarum extract (Ext) obtained by immunoblotting (d). Data are expressed as mean ± SD (n = 3).
Figure 1. SEM images (a) and NTA (b) of the rhubarb-enriched fraction of EVs. Particle distribution obtained by NTA on EV SEC fractions and NTA of fractions 7 and 8 with the ratio of the particle number per μg of the protein that is indicative of the protein enrichment of each EV isolation by SEC (c), with TET8 and Calnexin detection in enriched fractions (E.Fr) of EVs and Fr. 7 and Fr. 8 obtained by SEC and R. rhabarbarum extract (Ext) obtained by immunoblotting (d). Data are expressed as mean ± SD (n = 3).
Nutrients 17 03771 g001
Figure 2. DiL-labeled EV internalization by HDF AD cells with the nuclei marker DAPI (blue, DAPI filter), along with relative phalloidin and merged images (image magnification: 60×). In the upper panel, HDF AD cells treated with the extraction buffer processed through the same differential centrifugation and DiL-labeling procedure are reported; in the lower panel, HDF AD cells incubated with DiL-labeled EVs (1.10 × 106 particles) are reported.
Figure 2. DiL-labeled EV internalization by HDF AD cells with the nuclei marker DAPI (blue, DAPI filter), along with relative phalloidin and merged images (image magnification: 60×). In the upper panel, HDF AD cells treated with the extraction buffer processed through the same differential centrifugation and DiL-labeling procedure are reported; in the lower panel, HDF AD cells incubated with DiL-labeled EVs (1.10 × 106 particles) are reported.
Nutrients 17 03771 g002
Figure 3. Effect of rhubarb-derived EVs on viability, oxidative stress, and glycolytic metabolism. (a) MTT cell viability assay in CTRL and AD cells with different concentrations of rhubarb-derived EVs (particles per million). (b) ROS levels in CTRL, AD cells, and AD cells treated with 1.10 × 106 particles of rhubarb-derived EVs. (c) Representative Western blot images and densitometric analysis of oxidative stress-related proteins (Catalase, SOD1, and COX) in CTRL and AD cells, with and without EV treatment. (d) Seahorse Glycolytic Rate Assay results show GlycoPER, Basal GlycoPER, and Compensatory GlycoPER in CTRL, AD, and AD-treated cells. Data are expressed as mean ± SD; statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Figure 3. Effect of rhubarb-derived EVs on viability, oxidative stress, and glycolytic metabolism. (a) MTT cell viability assay in CTRL and AD cells with different concentrations of rhubarb-derived EVs (particles per million). (b) ROS levels in CTRL, AD cells, and AD cells treated with 1.10 × 106 particles of rhubarb-derived EVs. (c) Representative Western blot images and densitometric analysis of oxidative stress-related proteins (Catalase, SOD1, and COX) in CTRL and AD cells, with and without EV treatment. (d) Seahorse Glycolytic Rate Assay results show GlycoPER, Basal GlycoPER, and Compensatory GlycoPER in CTRL, AD, and AD-treated cells. Data are expressed as mean ± SD; statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Nutrients 17 03771 g003
Table 1. Antioxidant of rhubarb-derived EVs. Results are expressed as µmol of Trolox equivalent per 106 particles, and values are reported as means ± SD of three parallel measurements. Analyses were performed using Trolox as reference standards.
Table 1. Antioxidant of rhubarb-derived EVs. Results are expressed as µmol of Trolox equivalent per 106 particles, and values are reported as means ± SD of three parallel measurements. Analyses were performed using Trolox as reference standards.
µmol TE/106 ParticlesIC 50 (µg/106 Particles)
ABTS120.65 ± 6.757.50 ± 0.26
DPPH92.6 ± 11.454.5 ± 0.09
FRAP342.65 ± 6.9531.10 ± 2.85
CUPRAC722.50 ± 2.30250.80 ± 12.65
Table 2. Identification of polyphenol species in rhubarb-derived EVs through LC/MS. The concentration is reported as µg of compound detected in samples obtained from 4.4 × 109 particles, corresponding to the EV fraction isolated from 1 g of R. rhabarbarum.
Table 2. Identification of polyphenol species in rhubarb-derived EVs through LC/MS. The concentration is reported as µg of compound detected in samples obtained from 4.4 × 109 particles, corresponding to the EV fraction isolated from 1 g of R. rhabarbarum.
Identified Metabolite in Rhubarb-Derived EVsConcentration
(µg/gr of Starting Material)
(-)-epicatechin4.73 ± 1.89
Gallic acid2.66 ± 1.06
rhein2.48 ± 0.99
epicatechin gallate0.52 ± 0.21
Procyanidin B10.46 ± 0.18
Procyanidin B20.10 ± 0.04
6-Cinnamoyl-1-galloylglucose0.45 ± 0.18
Emodin0.25 ± 0.10
trans-4-Coumaric acid0.21 ± 0.08
Naringenin0.11 ± 0.04
Salicylic acid0.08 ± 0.03
Emodin 8-O-(beta)-D-glucoside0.04 ± 0.02
Methyl gallate0.04 ± 0.02
2-Hydroxyphenylacetic acid0.03 ± 0.01
[3,4,5-trihydroxy-6-[[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]oxan-2-yl] 3,4,5-trihydroxybenzoate0.03 ± 0.01
feruloyltyramine0.03 ± 0.01
Eriodictyol-7-O-glucoside0.02 ± 0.01
2,5-dihydroxy benzoic acid0.02 ± 0.01
Lecanoric Acid0.02 ± 0.01
Phloretin-2′-O-glucoside0.02 ± 0.01
1,6-Digalloyl-beta-D-glucopyranose0.01 ± 0.01
Biochanin-7-O-glucoside0.01 ± 0.00
Homoeriodictyol0.01 ± 0.00
Isoquercitrin0.01 ± 0.00
isorhamnetin-3-rutinoside0.01 ± 0.00
Kaempferol-3-O-glucoside-3″-rhamnoside0.01 ± 0.00
p-Hydroxybenzaldehyde0.01 ± 0.00
Quercitrin0.01 ± 0.00
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Calzoni, E.; Cusumano, G.; Bertoldi, A.; Alabed, H.B.R.; Pellegrino, R.M.; Buratta, S.; Urbanelli, L.; Zengin, G.; Emiliani, C. Rhubarb-Derived Extracellular Vesicles Mitigate Oxidative Stress and Metabolic Dysfunction in an Alzheimer’s Cellular Model. Nutrients 2025, 17, 3771. https://doi.org/10.3390/nu17233771

AMA Style

Calzoni E, Cusumano G, Bertoldi A, Alabed HBR, Pellegrino RM, Buratta S, Urbanelli L, Zengin G, Emiliani C. Rhubarb-Derived Extracellular Vesicles Mitigate Oxidative Stress and Metabolic Dysfunction in an Alzheimer’s Cellular Model. Nutrients. 2025; 17(23):3771. https://doi.org/10.3390/nu17233771

Chicago/Turabian Style

Calzoni, Eleonora, Gaia Cusumano, Agnese Bertoldi, Husam B. R. Alabed, Roberto Maria Pellegrino, Sandra Buratta, Lorena Urbanelli, Gokhan Zengin, and Carla Emiliani. 2025. "Rhubarb-Derived Extracellular Vesicles Mitigate Oxidative Stress and Metabolic Dysfunction in an Alzheimer’s Cellular Model" Nutrients 17, no. 23: 3771. https://doi.org/10.3390/nu17233771

APA Style

Calzoni, E., Cusumano, G., Bertoldi, A., Alabed, H. B. R., Pellegrino, R. M., Buratta, S., Urbanelli, L., Zengin, G., & Emiliani, C. (2025). Rhubarb-Derived Extracellular Vesicles Mitigate Oxidative Stress and Metabolic Dysfunction in an Alzheimer’s Cellular Model. Nutrients, 17(23), 3771. https://doi.org/10.3390/nu17233771

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop